114 related articles for article (PubMed ID: 7635919)
1. A two-site enzyme immunoassay for quantitation of human papillomavirus type 16 particles.
Eklund C; Dillner J
J Virol Methods; 1995 May; 53(1):11-23. PubMed ID: 7635919
[TBL] [Abstract][Full Text] [Related]
2. Human papillomavirus type 16 capsids expose multiple type-restricted and type-common antigenic epitopes.
Heino P; Skyldberg B; Lehtinen M; Rantala I; Hagmar B; Kreider JW; Kirnbauer R; Dillner J
J Gen Virol; 1995 May; 76 ( Pt 5)():1141-53. PubMed ID: 7537325
[TBL] [Abstract][Full Text] [Related]
3. Capture ElISA and in vitro cell binding assay for the detection of antibodies to human papillomavirus type 6b virus-like particles in patients with anogenital warts.
Peng S; Qi Y; Christensen N; Hengst K; Kennedy L; Frazer IH; Tindle RW
Pathology; 1999 Nov; 31(4):418-22. PubMed ID: 10643018
[TBL] [Abstract][Full Text] [Related]
4. A virus-like particle enzyme-linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16.
Kirnbauer R; Hubbert NL; Wheeler CM; Becker TM; Lowy DR; Schiller JT
J Natl Cancer Inst; 1994 Apr; 86(7):494-9. PubMed ID: 8133532
[TBL] [Abstract][Full Text] [Related]
5. Type-specific and cross-reactive antibodies induced by human papillomavirus 31 L1/L2 virus-like particles.
Xu Y; Wang Q; Han Y; Song G; Xu X
J Med Microbiol; 2007 Jul; 56(Pt 7):907-913. PubMed ID: 17577054
[TBL] [Abstract][Full Text] [Related]
6. Targeting synthetic Human Papillomavirus (HPV) L2 disulfide-induced N-terminus conformational epitopes for pan-HPV vaccine development.
Khanal S; Ferraris ED; Zahin M; Joh J; Ghim SJ; Jenson AB
Exp Mol Pathol; 2015 Oct; 99(2):330-4. PubMed ID: 26134615
[TBL] [Abstract][Full Text] [Related]
7. Reactivities of polyclonal and monoclonal antibodies raised to the major capsid protein of human papillomavirus type 16.
Patel D; Shepherd PS; Naylor JA; McCance DJ
J Gen Virol; 1989 Jan; 70 ( Pt 1)():69-77. PubMed ID: 2543739
[TBL] [Abstract][Full Text] [Related]
8. Broad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like Particles.
Boxus M; Fochesato M; Miseur A; Mertens E; Dendouga N; Brendle S; Balogh KK; Christensen ND; Giannini SL
J Virol; 2016 Jul; 90(14):6314-25. PubMed ID: 27147749
[TBL] [Abstract][Full Text] [Related]
9. HPV antibody detection by ELISA with capsid protein L1 fused to glutathione S-transferase.
Sehr P; Müller M; Höpfl R; Widschwendter A; Pawlita M
J Virol Methods; 2002 Oct; 106(1):61-70. PubMed ID: 12367730
[TBL] [Abstract][Full Text] [Related]
10. [Specific serologic studies with a novel authentic HPV antigen (virus-like particles) for HPV-6 antibodies in gynecologic patient samples].
Heim K; Christensen ND; Höpfl R; Wartusch B; Zeimet A; Larcher C; Ruth N; Bergant A; Pirschner G; Dierich MP
Gynakol Geburtshilfliche Rundsch; 1995; 35 Suppl 1():25-31. PubMed ID: 8672922
[TBL] [Abstract][Full Text] [Related]
11. Levels of immunoglobulin G antibodies against defined epitopes of the L1 and L2 capsid proteins of human papillomavirus type 6 are elevated in men with a history of condylomata acuminata.
Wikström A; Eklund C; Von Krogh G; Lidbrink P; Dillner J
J Clin Microbiol; 1992 Jul; 30(7):1795-800. PubMed ID: 1378454
[TBL] [Abstract][Full Text] [Related]
12. Surface conformational and linear epitopes on HPV-16 and HPV-18 L1 virus-like particles as defined by monoclonal antibodies.
Christensen ND; Dillner J; Eklund C; Carter JJ; Wipf GC; Reed CA; Cladel NM; Galloway DA
Virology; 1996 Sep; 223(1):174-84. PubMed ID: 8806551
[TBL] [Abstract][Full Text] [Related]
13. Antigenic and immunogenic epitopes shared by human papillomavirus type 16 and bovine, canine, and avian papillomaviruses.
Dillner L; Heino P; Moreno-Lopez J; Dillner J
J Virol; 1991 Dec; 65(12):6862-71. PubMed ID: 1719234
[TBL] [Abstract][Full Text] [Related]
14. Detection of antibodies to L1, L2, and E4 proteins of human papillomavirus types 6, 11, and 16 by ELISA using synthetic peptides.
Le Cann P; Chabaud M; Leboulleux D; Mougin C; Mayelo V; Legrand MC; Calvet C; Afoutou JM; Coll-Seck AM; Coursaget P
J Med Virol; 1995 Apr; 45(4):410-4. PubMed ID: 7545211
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus type 11 neutralization in the athymic mouse xenograft system: correlation with virus-like particle IgG concentration.
Bryan JT; Jansen KU; Lowe RS; Fife KH; McClowry T; Glass D; Brown DR
J Med Virol; 1997 Nov; 53(3):185-8. PubMed ID: 9365880
[TBL] [Abstract][Full Text] [Related]
16. A surface immunodeterminant of human papillomavirus type 16 minor capsid protein L2.
Kawana K; Matsumoto K; Yoshikawa H; Taketani Y; Kawana T; Yoshiike K; Kanda T
Virology; 1998 Jun; 245(2):353-9. PubMed ID: 9636375
[TBL] [Abstract][Full Text] [Related]
17. Serum IgG, IgM, and IgA reactivity to human papillomavirus types 11 and 6 virus-like particles in different gynecologic patient groups.
Heim K; Christensen ND; Hoepfl R; Wartusch B; Pinzger G; Zeimet A; Baumgartner P; Kreider JW; Dapunt O
J Infect Dis; 1995 Aug; 172(2):395-402. PubMed ID: 7542685
[TBL] [Abstract][Full Text] [Related]
18. [Study on the frequency of human papillomavirus type 6 and type 11 infection and L1 gene expression of the virus in biopsy samples of pointed condyloma patients].
Sun AH; Xu Y; Feng Y; Yan J
Zhonghua Liu Xing Bing Xue Za Zhi; 2006 Feb; 27(2):150-3. PubMed ID: 16749998
[TBL] [Abstract][Full Text] [Related]
19. Nasal immunization of mice with peptide having a cross-neutralization epitope on minor capsid protein L2 of human papillomavirus type 16 elicit systemic and mucosal antibodies.
Kawana K; Kawana Y; Yoshikawa H; Taketani Y; Yoshiike K; Kanda T
Vaccine; 2001 Jan; 19(11-12):1496-502. PubMed ID: 11163673
[TBL] [Abstract][Full Text] [Related]
20. Mapping of linear epitopes of human papillomavirus type 16: the L1 and L2 open reading frames.
Dillner J; Dillner L; Utter G; Eklund C; Rotola A; Costa S; DiLuca D
Int J Cancer; 1990 Mar; 45(3):529-35. PubMed ID: 1689705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
